Enantiomeric Determination of the Phenylmorpholinol Metabolite of Bupropion in Human Plasma Using Coupled Achiral-Chiral Liquid Chromatography
- 1 May 1997
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 11 (3) , 174-179
- https://doi.org/10.1002/(sici)1099-0801(199705)11:3<174::aid-bmc681>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- (2S,3S,5R)-2-(3,5-Difluorophenyl)-3,5- dimethyl-2-morpholinol: A Novel Antidepressant Agent and Selective Inhibitor of Norepinephrine UptakeJournal of Medicinal Chemistry, 1996
- Evidence that the Acute Behavioral and Electrophysiological Effects of Bupropion (Wellbutrin®) Are Mediated by a Noradrenergic MechanismNeuropsychopharmacology, 1994
- Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropionChirality, 1993
- Cardiovascular effects of bupropion in depressed patients with heart diseaseAmerican Journal of Psychiatry, 1991
- Antidepressant Profile of Bupropion and three Metabolites in MicePharmacopsychiatry, 1990
- Bupropion in DepressionArchives of General Psychiatry, 1988
- Chiral Separation of Cationic Drugs on an α1-Acid Glycoprotein Bonded Stationary PhaseJournal of Liquid Chromatography, 1986
- Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrineNeuropharmacology, 1986
- Stability of Bupropion and its Major Metabolites in Human PlasmaTherapeutic Drug Monitoring, 1985
- Determination of Bupropion and Its Major Basic Metabolites in Plasma by Liquid Chromatography With Dual-Wavelength Ultraviolet DetectionJournal of Pharmaceutical Sciences, 1984